The effect of gamma-tocopherol supplementation on gamma-tocopherol status, antioxidant capacity and nitrosative stress in apparently healthy smokers

ISRCTN ISRCTN99748080
DOI https://doi.org/10.1186/ISRCTN99748080
Protocol serial number 04-PG
Sponsor SafeFood, The Food Safety Promotion Board (Ireland)
Funder SafeFood, The Food Safety Promotion Board (Ireland) (ref: 04-PG)
Submission date
09/01/2008
Registration date
21/02/2008
Last edited
21/03/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Julie Wallace
Scientific

University of Ulster
Cromore Rd
Coleraine
BT52 1SA
United Kingdom

Study information

Primary study designInterventional
Study designDouble-blinded randomised placebo-controlled intervention study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleThe effect of gamma-tocopherol supplementation on gamma-tocopherol status, antioxidant capacity and nitrosative stress in apparently healthy smokers
Study objectivesAdditional dietary vitamin E will help alleviate risk of cardiovascular disease in apparently healthy smokers.
Ethics approval(s)University of Ulster Research Ethics Committee,13/05/2004, ref: 04/34
Health condition(s) or problem(s) studiedCardiovascular risk
InterventionOral supplementation of 100 mg of gamma-tocopherol or a placebo. Supplementation is provided for 6 months. There is no further follow-up after the post-intervention samples are collected.
Intervention typeSupplement
Primary outcome measure(s)

1. Tocopherol concentrations
2. Selenium concentrations
3. Inflammation markers

All primary outcome measures are assessed when samples are collected at baseline, month 3 and month 6.

Key secondary outcome measure(s)

1. Body composition measurements
2. Immune markers

All secondary outcome measures are assessed at baseline and month 6.

Completion date31/12/2008

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration70
Key inclusion criteria1. Consenting adult men and women
2. Smoke five or more cigarettes per day
3. Between 18 and 50 years of age
4. In general good health
Key exclusion criteria1. Non-smokers
2. Pregnancy
3. Diagnosed chronic disease
4. Those who take vitamin E containing supplements or prescribed medication
Date of first enrolment31/03/2006
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • United Kingdom
  • Northern Ireland
  • Ireland

Study participating centre

University of Ulster
Coleraine
BT52 1SA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

21/03/2017: No publications found, verifying study status with principal investigator.